Cerebral Amyloid Angiopathy Treatment Market: Why Does This Common...

agregó una foto Health

2026-07-22 09:32:14 -

Cerebral Amyloid Angiopathy Treatment Market: Why Does This Common Cause of Brain Bleeds Still Have Zero Approved Treatments?

The cerebral amyloid angiopathy (CAA) treatment market — therapies for a cerebrovascular condition in which amyloid protein deposits accumulate in and weaken small and medium blood vessels within the brain, causing recurrent lobar intracerebral hemorrhage and cognitive decline, particularly in older adults — remains defined by an almost complete absence of approved disease-modifying...

0 Commentarios 0 Acciones 5 Views 0 Vista previa